Goodwin Investment Advisory’s Amgen AMGN Stock Holding History

Goodwin Investment Advisory’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-194	Closed	-$48K	–	127
2021 Q1	$48K	Buy	+194	New	+$46.3K	0.06%	70

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goodwin Investment Advisory's AMGN Position: Q2 2021 in Review

Goodwin Investment Advisory sold out of Amgen (AMGN) in Q2 2021, closing a stake of 194 shares — an estimated $48K sold.

Goodwin Investment Advisory first reported a position in AMGN in Q1 2021 and held it in 1 quarter. The position peaked at $48K in Q1 2021. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

Goodwin Investment Advisory reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
Goodwin Investment Advisory sold 194 Amgen shares in Q2 2021, an estimated $48K.
Goodwin Investment Advisory first reported a position in Amgen in Q1 2021 and held it in 1 quarter.
Goodwin Investment Advisory's Amgen position peaked at $48K in Q1 2021.
2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Goodwin Investment Advisory's 13F filing for Q2 2021, filed 28 Jul 2021.